Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 20 jan 2022 - 08:00
  • Statutory name argenx SE
  • Title argenx Announces VYVGART™ Approval in Japan for the Treatment of Generalized Myasthenia Gravis

Related downloads

202201200000000002_Argenx_English.pdf

Date last update: 07 October 2022

Share information

Share on: Share this